ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,036Medicare Part D Prescriptions Filled, Including Refills

Rank: 311 out of 2888

$852K Total Retail Price of All Prescriptions

Rank: 305 out of 2888

402 Patients Receiving at Least One Drug in Part D
52%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 402 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

41% of this provider’s 402 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 6,782 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 799 308 S3 1 4
AMLODIPINE BESYLATE 597 315 2 5
SIMVASTATIN 441 253 3 2
FUROSEMIDE 429 297 4 6
CARISOPRODOL 418 101 R 5 82
LEVOTHYROXINE SODIUM 355 179 6 1
METOPROLOL SUCCINATE 330 163 7 11
LISINOPRIL 323 196 8 3
NEXIUM 248 103 9 19
OMEPRAZOLE 241 120 10 7
GABAPENTIN 231 110 11 13
METOPROLOL TARTRATE 227 142 12 10
POTASSIUM CHLORIDE 217 115 13 14
CLONIDINE HCL 212 113 14 39
METFORMIN HCL 211 113 15 8
CARVEDILOL 166 67 16 21
ZOLPIDEM TARTRATE 164 71 17 17
DONEPEZIL HCL 149 133 18 26
CRESTOR 146 98 19 20
WARFARIN SODIUM 143 103 20 22
FENTANYL 135 41 S2 21 126
HYDRALAZINE HCL 120 111 22 59
TAMSULOSIN HCL 117 78 23 29
MELOXICAM 116 47 24 31
TRAMADOL HCL 114 69 25 16
DIOVAN 114 101 25 35
SERTRALINE HCL 112 70 27 27
RISPERIDONE 111 45 28 72
KLOR-CON 8 111 80 28 265
PLAVIX 108 85 30 40
BUSPIRONE HCL 88 50 31 148
CLOPIDOGREL 86 58 32 30
ALLOPURINOL 86 57 32 37
SINGULAIR 85 20 34 85
RANITIDINE HCL 85 50 34 56
PROAIR HFA 83 31 36 71
NAMENDA 82 67 37 34
NIASPAN 78 27 38 127
ATENOLOL 75 42 39 25
JANUVIA 73 53 40 48
DEXILANT 69 34 41 186
HYDROCHLOROTHIAZIDE 68 46 42 15
AMLODIPINE BESYLATE-BENAZEPRIL 65 56 43 67
NIFEDIPINE ER 64 45 44 76
MORPHINE SULFATE ER 63 26 S2 45 229
LYRICA 60 30 46 69
ATORVASTATIN CALCIUM 60 33 46 9
EXFORGE 58 48 48 159
LOSARTAN POTASSIUM 58 49 48 18
GLIMEPIRIDE 57 49 50 36
FLUTICASONE PROPIONATE 56 21 51 32
RAMIPRIL 56 29 51 73
QUETIAPINE FUMARATE 56 26 51 66
PROMETHAZINE HCL 55 13 R 54 96
TOPIRAMATE 55 12 54 206
PHENYTOIN SODIUM EXTENDED 55 0 54 128
DIOVAN HCT 54 31 57 61
PREDNISONE 53 52 58 42
BENZTROPINE MESYLATE 52 12 R 59 191
POLYETHYLENE GLYCOL 3350 51 28 60 93
AZITHROMYCIN 50 18 61 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.